Search Results - "El Menshawe, Shahira F."

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    A novel transdermal nanoethosomal gel of lercanidipine HCl for treatment of hypertension: optimization using Box-Benkhen design, in vitro and in vivo characterization by Salem, Heba F., El-Menshawe, Shahira F., Khallaf, Rasha A., Rabea, Yasmine K.

    Published in Drug delivery and translational research (01-02-2020)
    “…Poor bioavailability of drugs via oral route is the greatest challenge facing drug formulation. To overcome this obstacle, transdermal route was commonly used…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Optimization and Appraisal of Nintedanib-Loaded Mixed Polymeric Micelles as a Potential Nanovector for Non-Invasive Pulmonary Fibrosis Mitigation by Aboud, Heba M, El Menshawe, Shahira F, Mohammed, Nada H, Tulbah, Alaa S, Ali, Adel A

    Published in Pharmaceuticals (Basel, Switzerland) (26-09-2024)
    “…Nintedanib (NTD), a triple tyrosine kinase receptor inhibitor, is the recommended first-line tackling option for idiopathic pulmonary fibrosis (IPF)…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Loratadine bioavailability via buccal transferosomal gel: formulation, statistical optimization, in vitro/in vivo characterization, and pharmacokinetics in human volunteers by Elkomy, Mohammed H., El Menshawe, Shahira F., Abou-Taleb, Heba A., Elkarmalawy, Marwa H.

    Published in Drug delivery (01-11-2017)
    “…Loratadine (LTD) is an antihistaminic drug that suffers limited solubility, poor oral bioavailability (owing to extensive first-pass metabolism), and highly…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation by Aboud, Heba M, Ali, Adel Ahmed, El-Menshawe, Shahira F, Elbary, Ahmed Abd

    Published in Drug delivery (01-09-2016)
    “…Development of carvedilol-loaded transfersomes for intranasal administration to overcome poor nasal permeability and hepatic first pass effect so as to enhance…”
    Get more information
    Journal Article
  8. 8

    Development, Optimization, and In Vitro/In Vivo Characterization of Enhanced Lipid Nanoparticles for Ocular Delivery of Ofloxacin: the Influence of Pegylation and Chitosan Coating by Eid, Hussein M., Elkomy, Mohammed H., El Menshawe, Shahira F., Salem, Heba F.

    Published in AAPS PharmSciTech (01-07-2019)
    “…This study aims to investigate whether modification of solid lipid nanoparticles (SLNs) with chitosan (CTS) and polyethylene glycol (PEG) coatings enhances…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Nanosized soy phytosome-based thermogel as topical anti-obesity formulation: an approach for acceptable level of evidence of an effective novel herbal weight loss product by El-Menshawe, Shahira F, Ali, Adel A, Rabeh, Mohamed A, Khalil, Nermeen M

    Published in International journal of nanomedicine (01-01-2018)
    “…Herbal supplements are currently available as a safer alternative to manage obesity, which has become a rising problem over the recent years. Many chemical…”
    Get full text
    Journal Article
  11. 11

    Development, Optimization, and Evaluation of Carvedilol-Loaded Solid Lipid Nanoparticles for Intranasal Drug Delivery by Aboud, Heba M., El komy, Mohammed H., Ali, Adel A., El Menshawe, Shahira F., Abd Elbary, Ahmed

    Published in AAPS PharmSciTech (01-12-2016)
    “…Carvedilol, a beta-adrenergic blocker, suffers from poor systemic availability (25%) due to first-pass metabolism. The aim of this work was to improve…”
    Get full text
    Journal Article
  12. 12

    Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery by El-Menshawe, Shahira F., Hussein, Amal K.

    Published in Pharmaceutical development and technology (01-07-2013)
    “…Context: Skin delivery of Meloxicam (MX) offers several advantages over the oral route which is associated with potential side effects. Objectives: The aim of…”
    Get full text
    Journal Article
  13. 13

    Development of a nanogel formulation for transdermal delivery of tenoxicam: a pharmacokinetic-pharmacodynamic modeling approach for quantitative prediction of skin absorption by Elkomy, Mohammed H., El Menshawe, Shahira F., Eid, Hussein M., Ali, Ahmed M. A.

    Published in Drug development and industrial pharmacy (03-04-2017)
    “…This study investigates potentials of solid lipid nanoparticles (SLN)-based gel for transdermal delivery of tenoxicam (TNX) and describes a…”
    Get full text
    Journal Article
  14. 14

    Skin permeation enhancement of nicotinamide through using fluidization and deformability of positively charged ethosomal vesicles: A new approach for treatment of atopic eczema by El-Menshawe, Shahira F., Sayed, Ossama M., Abou-Taleb, Heba A., El Tellawy, Nada

    “…For the treatment of atopic eczema, the drug penetration of the relevant skin layers is considered to be a major scientific concern. In this study, a new…”
    Get full text
    Journal Article
  15. 15
  16. 16

    A novel transdermal nanoethosomal gel of betahistine dihydrochloride for weight gain control: in-vitro and in-vivo characterization by El-Menshawe, Shahira F, Ali, Adel Ahmed, Halawa, Abdelkhalk Ali, Srag El-Din, Ahmed Sg

    Published in Drug design, development and therapy (01-01-2017)
    “…Betahistine dihydrochloride (BDH) is a histamine analog used to control weight gain, with short elimination half-life and gastric irritation as side effects…”
    Get full text
    Journal Article
  17. 17

    Betahistine dihydrochloride transdermal delivery via optimized thermosensitive gels: percutaneous absorption evaluation using rat growth as a biomarker by Elkomy, Mohammed Hassan, El-Menshawe, Shahira F., Ali, Adel Ahmed, Halawa, Abdelkhalik Ali, El-Din, Ahmed S. G. Srag

    Published in Drug delivery and translational research (01-02-2018)
    “…The aim of this study was to develop and optimize a betahistine dihydrochloride (BH) thermoreversible bioadhesive gel intended for transdermal delivery. The…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    The use of new quinazolinone derivative and doxorubicin loaded solid lipid nanoparticles in reversing drug resistance in experimental cancer cell lines: A systematic study by El-Menshawe, Shahira F., Sayed, Ossama M., Abou Taleb, Heba A., Saweris, Mina A., Zaher, Dana M., Omar, Hany A.

    “…The aim of this research is to study the feasibility of using carnauba wax as a new carrier for anticancer agents to deliver doxorubicin (DOX) as a model drug…”
    Get full text
    Journal Article